Click for best price
Artificial Intelligence Drug R&D Market Size, Share 2023
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug R&D. This report contains market size and forecasts of Artificial Intelligence Drug R&D in global, including the following market information:
Global Artificial Intelligence Drug R&D Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Artificial Intelligence Drug R&D market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AI Platfrom Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence Drug R&D include IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack and Nq Medical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Artificial Intelligence Drug R&D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence Drug R&D Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, by Type, 2022 (%)
AI Platfrom
Analytics Service
Global Artificial Intelligence Drug R&D Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, by Application, 2022 (%)
Drug Discovery
Precision Medicine
Global Artificial Intelligence Drug R&D Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Artificial Intelligence Drug R&D Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence Drug R&D revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Artificial Intelligence Drug R&D revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artificial Intelligence Drug R&D, market overview.
Chapter 2: Global Artificial Intelligence Drug R&D market size in revenue.
Chapter 3: Detailed analysis of Artificial Intelligence Drug R&D company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Intelligence Drug R&D in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Artificial Intelligence Drug R&D Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug R&D Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence Drug R&D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug R&D Overall Market Size
2.1 Global Artificial Intelligence Drug R&D Market Size: 2022 VS 2029
2.2 Global Artificial Intelligence Drug R&D Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug R&D Players in Global Market
3.2 Top Global Artificial Intelligence Drug R&D Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug R&D Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug R&D Companies in Global Market, by Revenue in 2022
3.5 Global Companies Artificial Intelligence Drug R&D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug R&D Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug R&D Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug R&D Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Artificial Intelligence Drug R&D Market Size Markets, 2022 & 2029
4.1.2 AI Platfrom
4.1.3 Analytics Service
4.2 By Type - Global Artificial Intelligence Drug R&D Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
4.2.2 By Type - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
4.2.3 By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence Drug R&D Market Size, 2022 & 2029
5.1.2 Drug Discovery
5.1.3 Precision Medicine
5.2 By Application - Global Artificial Intelligence Drug R&D Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
5.2.2 By Application - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
5.2.3 By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug R&D Market Size, 2022 & 2029
6.2 By Region - Global Artificial Intelligence Drug R&D Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug R&D Revenue, 2018-2023
6.2.2 By Region - Global Artificial Intelligence Drug R&D Revenue, 2024-2029
6.2.3 By Region - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug R&D Revenue, 2018-2029
6.3.2 US Artificial Intelligence Drug R&D Market Size, 2018-2029
6.3.3 Canada Artificial Intelligence Drug R&D Market Size, 2018-2029
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug R&D Revenue, 2018-2029
6.4.2 Germany Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.3 France Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.4 U.K. Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.5 Italy Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.6 Russia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.7 Nordic Countries Artificial Intelligence Drug R&D Market Size, 2018-2029
6.4.8 Benelux Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug R&D Revenue, 2018-2029
6.5.2 China Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.3 Japan Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.4 South Korea Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.5 Southeast Asia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.5.6 India Artificial Intelligence Drug R&D Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug R&D Revenue, 2018-2029
6.6.2 Brazil Artificial Intelligence Drug R&D Market Size, 2018-2029
6.6.3 Argentina Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, 2018-2029
6.7.2 Turkey Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.3 Israel Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.4 Saudi Arabia Artificial Intelligence Drug R&D Market Size, 2018-2029
6.7.5 UAE Artificial Intelligence Drug R&D Market Size, 2018-2029
7 Artificial Intelligence Drug R&D Companies Profiles
7.1 IBM Watson
7.1.1 IBM Watson Company Summary
7.1.2 IBM Watson Business Overview
7.1.3 IBM Watson Artificial Intelligence Drug R&D Major Product Offerings
7.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.1.5 IBM Watson Key News & Latest Developments
7.2 BioXel
7.2.1 BioXel Company Summary
7.2.2 BioXel Business Overview
7.2.3 BioXel Artificial Intelligence Drug R&D Major Product Offerings
7.2.4 BioXel Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.2.5 BioXel Key News & Latest Developments
7.3 Insilico Medicine
7.3.1 Insilico Medicine Company Summary
7.3.2 Insilico Medicine Business Overview
7.3.3 Insilico Medicine Artificial Intelligence Drug R&D Major Product Offerings
7.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.3.5 Insilico Medicine Key News & Latest Developments
7.4 Gatehouse Bio
7.4.1 Gatehouse Bio Company Summary
7.4.2 Gatehouse Bio Business Overview
7.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Major Product Offerings
7.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.4.5 Gatehouse Bio Key News & Latest Developments
7.5 Google DeepMind
7.5.1 Google DeepMind Company Summary
7.5.2 Google DeepMind Business Overview
7.5.3 Google DeepMind Artificial Intelligence Drug R&D Major Product Offerings
7.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.5.5 Google DeepMind Key News & Latest Developments
7.6 Genpact Cora
7.6.1 Genpact Cora Company Summary
7.6.2 Genpact Cora Business Overview
7.6.3 Genpact Cora Artificial Intelligence Drug R&D Major Product Offerings
7.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.6.5 Genpact Cora Key News & Latest Developments
7.7 Cyclica Inc
7.7.1 Cyclica Inc Company Summary
7.7.2 Cyclica Inc Business Overview
7.7.3 Cyclica Inc Artificial Intelligence Drug R&D Major Product Offerings
7.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.7.5 Cyclica Inc Key News & Latest Developments
7.8 QuantumBlack
7.8.1 QuantumBlack Company Summary
7.8.2 QuantumBlack Business Overview
7.8.3 QuantumBlack Artificial Intelligence Drug R&D Major Product Offerings
7.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.8.5 QuantumBlack Key News & Latest Developments
7.9 Nq Medical
7.9.1 Nq Medical Company Summary
7.9.2 Nq Medical Business Overview
7.9.3 Nq Medical Artificial Intelligence Drug R&D Major Product Offerings
7.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.9.5 Nq Medical Key News & Latest Developments
7.10 Phenomic AI
7.10.1 Phenomic AI Company Summary
7.10.2 Phenomic AI Business Overview
7.10.3 Phenomic AI Artificial Intelligence Drug R&D Major Product Offerings
7.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.10.5 Phenomic AI Key News & Latest Developments
7.11 Palantir Technologies
7.11.1 Palantir Technologies Company Summary
7.11.2 Palantir Technologies Business Overview
7.11.3 Palantir Technologies Artificial Intelligence Drug R&D Major Product Offerings
7.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue in Global Market (2018-2023)
7.11.5 Palantir Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Artificial Intelligence Drug R&D Market Opportunities & Trends in Global Market
Table 2. Artificial Intelligence Drug R&D Market Drivers in Global Market
Table 3. Artificial Intelligence Drug R&D Market Restraints in Global Market
Table 4. Key Players of Artificial Intelligence Drug R&D in Global Market
Table 5. Top Artificial Intelligence Drug R&D Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Artificial Intelligence Drug R&D Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Artificial Intelligence Drug R&D Revenue Share by Companies, 2018-2023
Table 8. Global Companies Artificial Intelligence Drug R&D Product Type
Table 9. List of Global Tier 1 Artificial Intelligence Drug R&D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Intelligence Drug R&D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Artificial Intelligence Drug R&D Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Artificial Intelligence Drug R&D Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2024-2029
Table 30. IBM Watson Company Summary
Table 31. IBM Watson Artificial Intelligence Drug R&D Product Offerings
Table 32. IBM Watson Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 33. IBM Watson Key News & Latest Developments
Table 34. BioXel Company Summary
Table 35. BioXel Artificial Intelligence Drug R&D Product Offerings
Table 36. BioXel Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 37. BioXel Key News & Latest Developments
Table 38. Insilico Medicine Company Summary
Table 39. Insilico Medicine Artificial Intelligence Drug R&D Product Offerings
Table 40. Insilico Medicine Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 41. Insilico Medicine Key News & Latest Developments
Table 42. Gatehouse Bio Company Summary
Table 43. Gatehouse Bio Artificial Intelligence Drug R&D Product Offerings
Table 44. Gatehouse Bio Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 45. Gatehouse Bio Key News & Latest Developments
Table 46. Google DeepMind Company Summary
Table 47. Google DeepMind Artificial Intelligence Drug R&D Product Offerings
Table 48. Google DeepMind Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 49. Google DeepMind Key News & Latest Developments
Table 50. Genpact Cora Company Summary
Table 51. Genpact Cora Artificial Intelligence Drug R&D Product Offerings
Table 52. Genpact Cora Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 53. Genpact Cora Key News & Latest Developments
Table 54. Cyclica Inc Company Summary
Table 55. Cyclica Inc Artificial Intelligence Drug R&D Product Offerings
Table 56. Cyclica Inc Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 57. Cyclica Inc Key News & Latest Developments
Table 58. QuantumBlack Company Summary
Table 59. QuantumBlack Artificial Intelligence Drug R&D Product Offerings
Table 60. QuantumBlack Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 61. QuantumBlack Key News & Latest Developments
Table 62. Nq Medical Company Summary
Table 63. Nq Medical Artificial Intelligence Drug R&D Product Offerings
Table 64. Nq Medical Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 65. Nq Medical Key News & Latest Developments
Table 66. Phenomic AI Company Summary
Table 67. Phenomic AI Artificial Intelligence Drug R&D Product Offerings
Table 68. Phenomic AI Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 69. Phenomic AI Key News & Latest Developments
Table 70. Palantir Technologies Company Summary
Table 71. Palantir Technologies Artificial Intelligence Drug R&D Product Offerings
Table 72. Palantir Technologies Artificial Intelligence Drug R&D Revenue (US$, Mn) & (2018-2023)
Table 73. Palantir Technologies Key News & Latest Developments
List of Figures
Figure 1. Artificial Intelligence Drug R&D Segment by Type in 2022
Figure 2. Artificial Intelligence Drug R&D Segment by Application in 2022
Figure 3. Global Artificial Intelligence Drug R&D Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Artificial Intelligence Drug R&D Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Artificial Intelligence Drug R&D Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2022
Figure 8. By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 9. By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 10. By Type - Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 12. By Application - Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 14. By Region - Global Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 15. By Country - North America Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 16. US Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 20. Germany Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 21. France Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 28. China Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 32. India Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 34. Brazil Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue Market Share, 2018-2029
Figure 37. Turkey Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2018-2029
Figure 41. IBM Watson Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioXel Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Insilico Medicine Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gatehouse Bio Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Google DeepMind Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Genpact Cora Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cyclica Inc Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. QuantumBlack Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nq Medical Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Phenomic AI Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Palantir Technologies Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
